Investigacion Biotecnologica

Investigación Biotecnológica (IB) is a pioneering Mexican biotechnology company founded in 1982, specializing in the research, development, and manufacturing of recombinant biopharmaceuticals. The company is widely recognized for developing the first Mexican recombinant vaccine against Hepatitis B, marking a significant milestone for the life sciences sector in Latin America. IB focuses on human health, particularly in the prevention of infectious diseases through advanced molecular biology and fermentation technologies. Based in Mexico City, the firm has historically collaborated with government entities like Birmex to enhance national vaccine production capabilities. Today, it continues to operate as a specialized developer of biological products and diagnostic reagents.